Skip to main content

Volume 9 Supplement 1

Proceedings of the 2009 Drug Discovery for Neurodegeneration Conference


Edited by Diana W Shineman and Howard M Fillit

The conference and the publication of these proceedings were supported by conference grant U13-AG031125 from the National Institute on Aging, the National Institute of Neurological Disorders and Stroke and the National Institutes of Health's Office of Rare Diseases. Other sponsors: CoMentis, Eli Lilly and Company, sanofi-aventis, Biogen Idec and The Michael J. Fox Foundation for Parkinson's Research

Drug Discovery for Neurodegeneration Conference. Go to conference site.

Washington, DC, USA2-3 February 2009

Annual Journal Metrics

  • Citation Impact
    2.903 - 2-year Impact Factor (2021)
    3.189 - 5-year Impact Factor (2021)
    1.094 - SNIP (Source Normalized Impact per Paper)
    0.772 - SJR (SCImago Journal Rank)

    50 days to first decision for all manuscripts (Median)
    58 days to first decision for reviewed manuscripts only (Median)

    2,598,639 Downloads (2021)
    2,061 Altmetric mentions (2021)

Sign up for article alerts and news from this journal